use of cefazolin for treatment of gram negative infections

This presentation provides an in-depth exploration of gram-negative bacterial infections, focusing on the role of cefazolin against EKP pathogens and the impact of updated CLSI guidelines on clinical practice. It delves into retrospective cohort study findings on community-onset EKP bacteremia, examining MIC stratification and its correlation with treatment outcomes. Key results highlight factors influencing therapy failure rates and mortality risks, supporting guideline revisions and...